Management of myocarditis in clinical practice.


Journal

Minerva cardiology and angiology
ISSN: 2724-5772
Titre abrégé: Minerva Cardiol Angiol
Pays: Italy
ID NLM: 101776555

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 30 10 2021
medline: 14 4 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

Myocarditis is an inflammatory heart muscle disease characterized by heterogeneous clinical presentation and outcome. Clinical heterogeneity of myocarditis, ranging from acute onset chest pain with electrocardiographic changes resembling an acute coronary syndrome, to arrhythmic storm and chronic decompensated heart failure, makes diagnosis challenging. However, a correct diagnosis is fundamental to proper patients' management and should always be seeked. Although a definite diagnosis is only provided by endomyocardial biopsy, the European Society of Cardiology task force on myocardial and pericardial diseases provided specific criteria for the diagnosis of clinically suspected myocarditis, which has been facilitated by the advent of noninvasive imaging tests (i.e. cardiovascular magnetic resonance based myocardial tissue characterization). Due to the heterogeneous presentation and disease course of myocarditis, a tailored treatment would be the best strategy, but a standardized management is still not available. However, over the years, new, promising therapies, such as antiviral and immune-suppressive treatment, have come side by side to the standard pharmacological heart treatment, i.e. antiheart failure medications. In this paper we will review the basic principles of myocarditis management in clinical practice, including diagnostic work-up, conventional and disease-specific therapy and patients' follow-up.

Identifiants

pubmed: 34713675
pii: S2724-5683.21.05732-X
doi: 10.23736/S2724-5683.21.05732-X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-284

Auteurs

Anna Baritussio (A)

Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.

Andrea S Giordani (AS)

Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.

Stefania Rizzo (S)

Unit of Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.

Giulia Masiero (G)

Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.

Sabino Iliceto (S)

Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.

Renzo Marcolongo (R)

Unit of Hematology and Clinical Immunology, Department of Medicine, University Hospital of Padua, University of Padua, Padua, Italy.

Alida L Caforio (AL)

Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy - alida.caforio@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH